Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Neoadjuvant therapy in early-stage breast cancer
Alvaro Moreno-Aspitia
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neoadjuvant therapy in early-stage breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Neoadjuvant Therapy
100%
Breast Neoplasms
55%
Drug Therapy
50%
Cytotoxins
32%
Biological Factors
15%
Adjuvant Chemotherapy
14%
Breast
10%
Biomarkers
9%
Survival
8%
Therapeutics
4%